The bioenteric balloon (BIB) or spatzs ballon are widely applied in the management of obesity. This is a report on the efficacy and safety of Ballon device in the first 106 cases. Patients referred for Balloon between 2015 till 2016 were evaluated retrospectively. Balloon was inserted for 6 months according to predetermined inclusion and exclusion criteria. In 106 cases, 22 cases were males (16.8%) and 84 cases were females (83.2%), mean age 33.2 (±10.44) years, mean BMI 35.9 (±4.65) kg/m2. None of the patients exhibited balloon migration or perforation. The balloon was removed upon request in 3 patients due to exaggerated intolerance (2.9%). The mean weight loss was 15.5 kg (±4.67), mean EWL 64.12% (±23.48%). The mean BMI at extraction was 29.7 kg/m2 (±4.48) with a BMI loss of 6.2 kg/m2 (±2.0). 87 patients (88.7%) achieved target EWL (32.1% of excess weight), and 87 patients lost >12.2% of their basal weight (88.7%). 70 patients achieved BMI loss >5.7 kg/m2 (71.4%). BIB and spatzs balloon achieves acceptable success with minimal complications. In further long term, prospective studies are needed to evaluate obesity related comorbidities when using such modality and to compare it to other available devices.
Keywords: American Balloon, Bioenteric Balloon, Obesity, Weight Loss, spatzs balloon
